NCT05771558Completed
The Effect of a Lighting Intervention on Sleep in Parkinson Disease
Non-motor Features of Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 16 Jul 2025
Brief summary (registry, in English)
50 participants with Parkinson's disease will be recruited to complete actigraphy studies to assess sleep disturbances. For this, participants will wear an Actigraph for seven days. Thirty of these participants with sleep disturbance will go on to receive a tailored lighting intervention (TLI) to assess the effect on sleep, fatigue, and circadian entrainment via urinary melatonin levels.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 21 Feb 2023
- Start date
- 14 Nov 2022
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Diseases
- Parkinson disease
- NCT number
- NCT05771558
What you commit to
- Study type: Interventional
- Participants enrolled: 48
- From 14 Nov 2022 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- There are no exclusion criteria
Who the study is looking for
- Diagnosis of Parkinson's disease and difficulties with sleep and/or cognition
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mount Sinai Beth Israel Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.